RAPD技术在中药材道地性鉴定中的应用.pdf

2 8 2 1 5 Ferrario CM T he role of angiotensin antagonism in stroke prevention and hydrochlorothiazide in elderly and younger patientsJCurrent in patients w ith hypertension: focus on losartanCurrent medical re- T herapeutic Research1996, 57( 5) : 16 search and opinionJNov 2 4, 2 ( 11) : 1797-18 4 11Goldberg AI, Dunlay MC, Sw eet CSSafety and tolerability of losar- 6, , / tan potassium, an angiotensin receptor antagonist, compared w ith J , 2 7, 1 hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-con- ( 2) : 192-193 verting enzyme inhibitors for the treatment of systemic hypertension 7Dezii CM A retrospective study of persistence w ith single-pill combi- JT he American Journal of CardiologyApr 1995, 75( 12) : 793- nation therapy vsconcurrent tw o-pill therapy in patients w ith hyper- 795 tension JM anaged care( Langhorne, PaSep 2 , 9( 9 Suppl) : 2-6 12Soffer BA, Wright JT, Jr, Pratt JH, Wiens B, Goldberg AI, Sw eet 8Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC , Motola CSEffects of losartan on a background of hydrochlorothiazide in D, Sangiorgi Cellini G, Vaccheri A, De PontiF, Montanaro NInitial patiens w ith hypertensionJ HypertensionJul 1995, 26( 1) : 112- treatment of hypertension and adherence to therapy in general practice 117 in ItalyJ European Journal of Clinical PharmacologySep 2 5, 61 13Ohnishi K, Kohno M, Yukiiri K, Masugata H, Wada Y, Takagi Y, ( 8) : 6 3-6 9 Ohmori KInfluence of the angiotensin receptor antagonist losar- 9Conlin PR, Spence JD, Williams B, Ribeiro AB, Saito I, Benedict C, tan on diuretic-induced metabolic effects in elderly hypertensive pa- Bunt AMAngiotensin antagonists for hypertension: are there dif- tiens: comparison w ith a calcium channel blocker J Inter